Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07402863 · ClinicalTrials.gov registry record · NA

Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc)

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT07402863 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 43 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07402863, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

The goal of this clinical trial is to gather information on the RENEW app used by people with scleroderma. Specifically, the researchers want to learn more about RENEW by collecting information about the rates of recruitment, retention of study participants information about study completion, and time spent accessing the app content.

Interventions

  • DEVICE RENEW

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2025-01-28
Est. Completion 2025-07-28
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT07402863

The ClinicalTrials.gov registry entry for NCT07402863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which RENEW is the first listed.

NCT07402863 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07402863 about?

NCT07402863 is a clinical study titled "Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc)". The goal of this clinical trial is to gather information on the RENEW app used by people with scleroderma. Specifically, the researchers want to learn more about RENEW by collecting information about the rates of recruitment, retention of study participants information about study completion, and ti...

What is the current status of trial NCT07402863?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2025-01-28. Estimated completion is 2025-07-28.

What interventions are being tested in trial NCT07402863?

The interventions under investigation include: RENEW (DEVICE).

Who is sponsoring clinical trial NCT07402863?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.